Table 3.
Publications on Gallbladder Cancer and PET
| Gallbladder cancer | ||||
|---|---|---|---|---|
| Author | Year | N | Conclusion | |
| Rodriguez-Fernandez | 2004 | 16 | Sensitivity and specificity of 80% and 82% in identifying GBC in patients with biliary colic | Accurate method of differentiating malignant from benign gallbladder disease |
| Petrowsky | 2006 | 14 | Identified 14 out of 14 with primary or recurrent GBC compared to 10 out of 14 using CT | Comparable in detecting GBC compared to CT |
| Corvera | 2007 | 31 | Sensitivity of 86% in identifying primary GBC Identified 24 out of 28 patients with primary GBC (Sens: 86%) | High detection rate for GBC |
| Metastasis | ||||
| Petrowsky | 2006 | 14 | Identified 7 out of 7 distant metastases in patients with GBC but only identified 2 out of 17 patients with biliary cancer and regional spread | Good for detecting distant but not regional lymph metastasis |
| Corvera | 2007 | 31 | Sensitivity of 87% in identifying metastatic GBC; 7 patients had metastases not previously seen, avoiding surgery in 4 patients | Valuable in detecting metastatic GBC not previously seen |
| Recurrence | ||||
| Anderson | 2004 | 14 | Sensitivity of 78% in detecting residual GBC after cholecystectomy | Good for detecting residual GBC |
GBC: Gallbladder cancer; PET: Positron emission tomography; US: Ultrasound; CT: Computed tomography; MRI: Magnetic resonance imaging; RFA: Radio frequency ablation; FDG: Fluorine-18-fluorodeoxyglucose; SUV: Standardized uptake value; Sens: Sensitivity; Spec: Specificity